A nurse is caring for a 68-year-old patient with chronic heart failure who was admitted with acute exacerbation. The patient has been receiving IV furosemide for 3 days and shows signs of improvement. During the morning assessment, which finding would be the MOST important for the nurse to report to the healthcare provider immediately?

A serum potassium of 2.8 mEq/L with muscle weakness indicates severe hypokalemia, which can cause life-threatening arrhythmias in a heart failure patient on furosemide and requires immediate reporting. Other findings (BP decrease, weight loss, high urine output) are expected responses to diuretic therapy.

Core Nursing Explanation This question tests the nurse's ability to prioritize patient safety by recognizing a life-threatening complication of a common medication in a vulnerable patient population. The core theme is medication side effect monitoring and electrolyte imbalance in the context of heart failure management. Key Concept Analysis: The patient has Chronic Heart Failure (CHF) and is receiving IV Furosemide, a potent loop diuretic. While effective for reducing fluid overload, furosemide causes significant potassium loss in the urine, leading to Hypokalemia (low serum potassium). In a patient with heart disease, hypokalemia is particularly dangerous as it increases cardiac excitability and the risk of life-threatening arrhythmias like ventricular tachycardia or fibrillation. Answer Rationale: Key Point! A serum potassium level of 2.8 mEq/L is severely low (normal range is typically 3.5-5.0 mEq/L). When combined with the new symptom of muscle weakness—a classic sign of hypokalemia affecting skeletal and cardiac muscle—this represents an urgent, potentially life-threatening situation that requires immediate intervention (e.g., potassium supplementation, cardiac monitoring). This finding takes absolute priority. Distractor Analysis: Watch out for confusion! It's easy to be distracted by other data that seems "abnormal," but you must interpret them within the clinical context of successful diuresis.
• Option 1: A blood pressure decrease from 140/90 to 120/80 mmHg is likely a desired therapeutic effect of reducing preload and afterload in heart failure. It is not hypotensive and indicates improved hemodynamics.
• Option 3: Daily weight loss and decreased edema are expected and positive outcomes of effective diuretic therapy, showing the treatment is working.
• Option 4: High urine output with clear yellow urine is the intended pharmacological action of furosemide. It indicates effective diuresis without signs of dehydration (the urine is not concentrated). Related Concepts: This integrates knowledge of pharmacology (loop diuretic action), fluid and electrolyte balance, and cardiac nursing. The nurse's role is to balance the therapeutic benefits of diuresis with vigilant monitoring for its dangerous side effects. Concept Summary • Primary Issue: Life-threatening hypokalemia from loop diuretic (Furosemide) therapy. • Pathophysiology: K+ loss in urine → decreased serum K+ → increased cardiac cell excitability → risk of lethal arrhythmias. • Priority Action: Immediate reporting for potassium replacement and cardiac monitoring. • Nursing Process: Assessment (lab values, symptoms) → Recognition of urgent problem → Communication/Reporting → Intervention. Side-by-Side Comparison!

Finding	Interpretation in CHF on Diuretics	Priority
K+ = 2.8 mEq/L with weakness	Critical Abnormality. Life-threatening arrhythmia risk.	HIGHEST (Report immediately)
BP 140/90 → 120/80 mmHg	Therapeutic Improvement. Reduced cardiac workload.	Low (Monitor)
2 lb weight loss, less edema	Therapeutic Goal Achieved. Effective fluid removal.	Low (Document)
UO 150 mL/hr, clear urine	Expected Drug Effect. Effective diuresis, good hydration.	Low (Monitor for excess)

Anatomy, Physiology & Pharmacology Points • Furosemide (Lasix): Loop diuretic. Acts on the ascending loop of Henle in the kidney, inhibiting Na+/K+/2Cl- cotransporter. Causes excretion of Na+, K+, Cl-, and water. • Potassium (K+): Critical for resting membrane potential of cardiac cells. Low K+ (

Nursing Clinical Practice Guide Clinical Scenario: You are the day-shift nurse for Mr. Johnson, a 68-year-old with a history of ischemic cardiomyopathy admitted for acute CHF exacerbation. He has received IV furosemide 40 mg BID for three days. His breath sounds are clearer, and he states he feels less short of breath. During your morning assessment, he mentions his legs feel "heavy and weak" when trying to stand. You review his morning labs. Nursing Intervention Strategy: 1. Immediate Assessment & Safety: * Vital Signs & Cardiac Monitor: Check BP, HR, rhythm. Place him on continuous cardiac monitoring if not already. Assess for irregular pulse. * Neuromuscular: Test muscle strength in all extremities. Ask about other symptoms: cramps, paresthesia (tingling), nausea, abdominal distension (signs of ileus). * Review ALL Electrolytes: Check for concomitant abnormalities like hypomagnesemia (Mg2+), which can make hypokalemia harder to correct. 2. Communication & Reporting (SBAR): * Situation: "Dr. Smith, this is Nurse Lee calling about Mr. Johnson in room 412." * Background: "He is a 68-year-old CHF patient on day 3 of IV Lasix." * Assessment: "His morning K+ is 2.8, and he has new-onset bilateral lower extremity weakness. He is on the monitor; rhythm is currently sinus with occasional PVCs." * Recommendation: "I am requesting orders for potassium replacement and possibly a magnesium level check. Should we hold the next dose of Lasix?" 3. Implementation of Orders: * Potassium Replacement: Administer oral or IV potassium chloride (KCl) as ordered. Key Point! IV potassium must be given slowly and diluted (e.g., no more than 10 mEq/hr via peripheral line, 20-40 mEq/hr via central line with cardiac monitoring) to prevent fatal hyperkalemia or phlebitis. * Monitoring: Recheck potassium levels per protocol. Monitor urine output closely. Patient Safety and Precautions: * Never administer IV potassium via IV push—it is lethal. * Patients on digoxin (common in CHF) are extremely sensitive to hypokalemia, which can precipitate digoxin toxicity even at therapeutic digoxin levels. * Always assess for adequate renal function (creatinine, BUN) before giving potassium supplements. Nursing Procedure & Medication Flow Managing a Patient on Loop Diuretics: 1. Pre-Administration: Assess baseline weight, lung sounds, edema, electrolytes (especially K+, Na+, Mg2+). 2. Administration: Give IV furosemide as ordered, often given over 1-2 minutes. Monitor for transient ototoxicity (hearing loss/tinnitus). 3. Post-Administration Monitoring (1-2 hours): * Urine Output (UO): Expect increased UO. Report if < 30 mL/hr (possible renal impairment). * Vital Signs: Monitor for hypotension, especially orthostatic. * Daily Weights: Same scale, same time, same clothing. Goal: 1-2 lb/day loss. 4. Long-Term Monitoring & Education: * Teach patient to eat K+-rich foods (bananas, oranges, potatoes, tomatoes) if allowed. * Recognize signs of hypokalemia (weakness, fatigue, palpitations) and hyperkalemia (muscle twitching, paresthesia, bradycardia). * Adhere to daily weight monitoring at home. A Word from Your Senior Nurse "In the fast-paced world of heart failure management, diuretics are our powerful allies, but they come with sharp edges. Your vigilance is the safety net. That moment when you connect a patient's vague complaint of 'weakness' with a critically low potassium level is where textbook knowledge saves a life. On the NCLEX and at the bedside, never underestimate the combination of a symptom and an abnormal lab value—it's your cue to escalate. Think like a detective, act like a guardian."